For the year ending 2025-12-31, IMUX has $24,052K in assets. $30,725K in debts. $15,483K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 15,483 | |||
| Prepaid expenses and other current assets | 7,386 | |||
| Total current assets | 22,869 | |||
| Property and equipment, net | 608 | |||
| Right of use asset, net | 575 | |||
| Total assets | 24,052 | |||
| Accounts payable | 10,138 | |||
| Accrued expenses | 18,645 | |||
| Other current liabilities | 1,835 | |||
| Total current liabilities | 30,618 | |||
| Operating lease liabilities | 107 | |||
| Total long-term liabilities | 107 | |||
| Total liabilities | 30,725 | |||
| Common stock, 0.0001 par value 500,000,000 shares authorized as of december 31, 2025 and december 31, 2024, respectively, and 120,382,625 and 90,150,869 shares issued and outstanding as of december 31, 2025 and december31, 2024, respectively | 9 | |||
| Additional paid-in capital | 599,241 | |||
| Accumulated other comprehensive income | 2,648 | |||
| Accumulated deficit | -608,571 | |||
| Total stockholders equity (deficit) | -6,673 | |||
| Total liabilities and stockholders equity (deficit) | 24,052 | |||
IMMUNIC, INC. (IMUX)
IMMUNIC, INC. (IMUX)